EE291 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study Interim Analysis of Tildrakizumab in Patients with Moderate to Severe Psoriasis
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.536
https://www.valueinhealthjournal.com/article/S1098-3015(22)00737-9/fulltext
Title :
EE291 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study Interim Analysis of Tildrakizumab in Patients with Moderate to Severe Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00737-9&doi=10.1016/j.jval.2022.04.536
First page :
Section Title :
Open access? :
No
Section Order :
10478